Our Bureau, Mumbai Monday, January 5, 2026, 09:00 Hrs [IST] ...
IP 2026 introduces blood component quality standards in transfusion medicine for the first time: Shardul Nautiyal, Mumbai Monday, January 5, 2026, 08:00 Hrs [IST] The Indian Pharm ...
Haryana FDA issues strict directive on labelling & sale of high-risk industrial-grade solvents & excipients: Peethaambaran Kunnathoor, Chennai Monday, January 5, 2026, 08:00 Hrs [ ...
Karnataka has urged the Centre to establish a National Institute of Pharmaceutical Education and Research (NIPER) in the state, citing its strong pharmaceutical and biotechnology ecosystem, skilled ...
Panel asks Ayush Ministry to conduct mid-term evaluations of schemes & projects: Gireesh Babu, New Delhi Monday, January 5, 2026, 08:00 Hrs [IST] The Parliamentary Panel on Health ...
The Parliamentary Panel on Health and Family Welfare has recommended to the Ministry of Ayush to approach the Ministry of Finance seeking extension of the National Ayush Mission (NAM) for another five ...
Novo Nordisk announces China’s Supreme People’s Court delivers positive ruling on semaglutide compound patent: Bagsværd, Denmark Saturday, January 3, 2026, 17:00 Hrs [IST] Th ...
Pharma industry leaders spotlight quality, sustainability and market diversification as export priorities for 2026: Our ...
BioAtla and GATC Health announce $40 million SPV transaction to advance ozuriftamab vedotin into a registrational trial for 2L+ OPSCC: San Diego Saturday, January 3, 2026, 18:00 H ...
Advances in technology transforming the approach to prostate cancer: Dr Likhiteswer Pallagani: Shardul Nautiyal, Mumbai ...
Corcept receives US FDA Complete Response Letter for relacorilant as a treatment for patients with hypercortisolism: Redwood City, California Saturday, January 3, 2026, 14:00 Hrs ...
Xortx Therapeutics announces pioneering research on genome-wide pathogenic pathways in gout: Calgary, Alberta Saturday, January 3, 2026, 13:00 Hrs [IST] Xortx Therapeutics Inc., a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results